Xcout IntelNuwellis
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Subscribe to see Nuwellis’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Nuwellis at a glance
Nuwellis is a medical devices company headquartered in Eden Prairie, United States. It is publicly listed (NUWE) with a market capitalisation of $116,173. Xcout tracks 38 named people at Nuwellis, including John L. Erb (CEO, President & Chairman).
Nuwellis leadership
- John L. ErbCEO, President & Chairman
- Michael Kendrick McCormickPresident, Chief Executive Officer & Director
- Carisa SchultzCFO, Principal Financial Officer & Principal Accounting Officer
- Rob ScottChief Financial Officer
- David LernerChief Technology Officer
- Neil AyotteSenior Vice President, General Counsel, Secretary & Chief Compliance Officer
32 more named people on record for Nuwellis, with roles, board committees and tenure — see the full roster →
Recent Nuwellis news
- Leadership changeNuwellis (NUWE) Appoints New CEO in Leadership Transition
3 corporate events on record, with sources — see the full timeline →
Nuwellis competitors
A few of Nuwellis's closest competitors — see the full list of competitors and alternatives →
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.
WhiteSwell is a clinical-stage medical technology company headquartered in Galway, Ireland. The company pioneers device-based treatments for acute decompensated heart failure by targeting and supporting the human lymphatic system.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Phraxis Inc. is a medical device company based in Minneapolis, Minnesota, dedicated to redefining outcomes in vascular access for hemodialysis patients. The company specializes in endovascular technologies such as its EndoForce device.
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
Get Nuwellis's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Nuwellis in Xcout Intel
- 38 named people with titles, LinkedIn and board committees
- 3 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access